Sign up for e-mail alerts
|
Login
|
About PlusNews
|
Français
PlusNews
Global HIV/AIDS news and analysis
Advanced Search
GLOBAL
AFRICA
East Africa
Kenya
Sudan
Tanzania
Uganda
Great Lakes
Burundi
Central African Republic
Congo
DRC
Rwanda
Horn of Africa
Djibouti
Eritrea
Ethiopia
Somalia
Southern Africa
Angola
Botswana
Comoros
Lesotho
Madagascar
Malawi
Mauritius
Mozambique
Namibia
Seychelles
South Africa
Swaziland
Zambia
Zimbabwe
West Africa
Benin
Burkina Faso
Cameroon
Cape Verde
Chad
Cote d'Ivoire
Gabon
Gambia
Ghana
Equatorial Guinea
Guinea
Guinea-Bissau
Liberia
Mali
Mauritania
Niger
Nigeria
Sao Tome and Principe
Senegal
Sierra Leone
Togo
Western Sahara
ASIA
Afghanistan
Cambodia
Indonesia
Kyrgyzstan
Myanmar
Nepal
Pakistan
Papua New Guinea
Philippines
Sri Lanka
Thailand
Uzbekistan
MIDDLE EAST
Egypt
Iraq
Jordan
Lebanon
OPT
Yemen
AMERICAS
Haiti
25 May 2011
Home
Global Issues
In-Depth
Blog
Events
IRIN
Film
Weekly Reports
Countries
Afghanistan
Angola
Bangladesh
Benin
Botswana
Burkina Faso
Burundi
Cambodia
Cameroon
Cape Verde
Central African Republic (CAR)
Chad
Comoros
Republic of Congo
Cote d'lvoire
Djibouti
Democratic Republic of Congo (DRC)
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Haiti
Indonesia
Iran
Iraq
Jordan
Kenya
Kyrgyzstan
Laos
Lebanon
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mozambique
Myanmar
Namibia
Nepal
Niger
Nigeria
occ. Palestinian terr.
Pakistan
Papua New Guinea
Philippines
Rwanda
Sao Tome and Principe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
Sri Lanka
Sudan
Swaziland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Turkmenistan
Uganda
Uzbekistan
Western Sahara
Yemen
Zambia
Zimbabwe
Themes
Aid Policy
Arts/Culture
Care/Treatment
Children
Conflict
Early Warning
Economy
Education
Environment
Food Security
Gender Issues
Governance
Health & Nutrition
HIV/AIDS
Media
Migration
Prevention
PWAs/ASOs
Stigma/Human Rights/Law
Urban Risk
Youth
In-depth: AIDS 2008: PlusNews in Mexico
GLOBAL: Is there still hope for an HIV vaccine?
Photo:
Kristy Siegfried/PlusNews
A volunteer receives a dose of a trial HIV vaccine
Mexico City, 5 August 2008 (PlusNews) - The road to finding an effective HIV vaccine has recently been marked by a string of disappointing setbacks, and researchers have warned that a breakthrough in this field is still a long way off. Should we give up hope?
Delegates at the International AIDS Conference in Mexico City heard on Monday that the search for a vaccine to protect against HIV infection was one of the most difficult endeavours ever, with vaccine science still "more an art than a science".
In the past year, one
major vaccine trial
was halted after early results showed that not only did the candidate not protect people from the virus, it may actually have put them at increased risk of becoming infected.
Last month, the US National Institute of Allergy and Infectious Diseases (NIAID) announced it would not move ahead with a vaccine trial involving 8,500 participants, which was intended to test a candidate with similarities to the one that failed last year.
These developments have left the vaccine field reeling, with people in some quarters calling for public funding of AIDS vaccine research to be ended or diverted toward existing HIV treatment and prevention interventions.
But Tachi Yamada, executive director of the Bill and Melinda Gates Foundation's Global Health Programme, a major funder of vaccine research, told delegates that the recent failures in HIV vaccine trials were no reason to give up hope.
This is not a time to step away and invest less...we need to move forward with big investments
"This is not a time to step away and invest less...we need to move forward with big investments. We have to be unafraid to fail," he said.
According to Yamada, scientists have very little predictive knowledge of whether vaccine candidates will work. He called for better animal models for the testing of candidate vaccines, as existing models could not predict effects on humans.
Another challenge for clinical trials was that participants did not always follow instructions, making it more difficult to demonstrate a vaccine's effects.
Unrealistic expectations on the part of the public also continued to be a problem. "When a trial goes wrong, the immediate assumption is that it was a bad investment," said Yamada, who called for more to be done to educate the public about HIV prevention research.
Alan Bernstein, director of the Global HIV Vaccine Enterprise, admitted that the search for an effective vaccine was "at a critical crossroads". He told delegates that the challenge now was to
design trials
that would "advance our understanding of the human immune response to HIV".
kn/ks
See also:
Trials and Tribulations of HIV Prevention Research
AIDS 2008: PlusNews in Mexico
Blog
Stiletto heels and sewing machines
.
Humanitarian work - it's the new black
.
Sexing up safer sex
.
Getting hot under the collar at conferences
.
Politics, prevention and party dresses
.
The last taboo?
News Map
Hear our Voices
Lucy Chesire: "The three big scars in my life are because of TB-HIV co-infection"
Maura Elaripe: "I was forced to go through sterilisation and up to now I regret it"
Previous Conference Coverage
Microbicides 2008
GLOBAL: ARVs in microbicide research - keeping hope alive?
GLOBAL: Less silence, more science could make anal sex safer
GLOBAL: Microbicides in the bedroom
South Africa TB Conference 2008
SOUTH AFRICA: Drug-resistant TB demands new approaches
SOUTH AFRICA: TB plan has a gap between talk and action
SOUTH AFRICA: TB treatment programmes failing
HIV/AIDS Implementer's Meeting 2008
AFRICA: Tailoring the HIV response to fit the epidemic
UGANDA: Routine HIV testing boosts uptake
AFRICA: Armies grapple with HIV among troops
International Congress on AIDS in Asia and the Pacific 2007
ASIA: "Seize the opportunities of hope"
ASIA: No room for transgender people in HIV funding
ASIA: Migrants find the greener grass has higher risks
Links & References
AIDS 2008
2008 Report on the Global AIDS Epidemic
In-Depth Feedback
PlusNews welcomes feedback. Send your messages to feedback.
Other OCHA Sites
Donors